CORRECTING LIPID EXCHANGE IN PATIENTS WITH OBLITERATING ATHEROSCLEROSIS OF LOWER LIMB VESSELS WITH FUCUS EVANESCENS-DERIVED SULPHATED POLYSACCHARIDE
Abstract
Summary - The authors estimate efficiency of applying biologically
active additive Fucolam derived from brown algae Fucus evanescens
as a part of comprehensive treatment of patients suffering
from obliterating atherosclerosis of lower limb vessels in effort to
correct lipid and carbohydrate metabolism. The study group included
patients with dislipidemy caused by increased levels of total
cholesterol, triglycerides, low-density lipoproteins, and atherogenicity
coefficient. The patients were prescribed to apply Fucolam
by two capsules a day during 21 days. As reported, application of
biologically active additive as a scheme of conservative treatment of
obliterating atherosclerosis allows stabilising cholesterol distribution
between the lipoprotein fractions and decreasing atherogenicity
coefficient.
active additive Fucolam derived from brown algae Fucus evanescens
as a part of comprehensive treatment of patients suffering
from obliterating atherosclerosis of lower limb vessels in effort to
correct lipid and carbohydrate metabolism. The study group included
patients with dislipidemy caused by increased levels of total
cholesterol, triglycerides, low-density lipoproteins, and atherogenicity
coefficient. The patients were prescribed to apply Fucolam
by two capsules a day during 21 days. As reported, application of
biologically active additive as a scheme of conservative treatment of
obliterating atherosclerosis allows stabilising cholesterol distribution
between the lipoprotein fractions and decreasing atherogenicity
coefficient.
About the Authors
К. Майстровский
НИИ эпидемиологии и микробиологии СО РАМН
Russian Federation
Russian Federation
Т. Запорожец
НИИ эпидемиологии и микробиологии СО РАМН
Russian Federation
Russian Federation
В. Раповка
Владивостокский государственный медицинский университет
Russian Federation
Russian Federation
Т. Звягинцева
Тихоокеанский институт биоорганической химии ДВО РАН
Russian Federation
Russian Federation
Н. Шевченко
Тихоокеанский институт биоорганической химии ДВО РАН
Russian Federation
Russian Federation
K. V. Maistrovsky
Vladivostok State Medical University
Russian Federation
Russian Federation
T. S. Zaporozhetz
Vladivostok State Medical University
Russian Federation
Russian Federation
V. G. Rapovka
Research Institute of Epidemiology
and Microbiology, Siberian Branch of RAMS
Russian Federation
Russian Federation
T. N. Zvyagintseva
Pacific Institute of Bioorganic
Chemistry, FEB RAS
Russian Federation
Russian Federation
N. M. Shevchenko
Pacific Institute of Bioorganic
Chemistry, FEB RAS
Russian Federation
Russian Federation
References
1. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Российские рекомендации. IV пересмотр. М., 2009 // URL: http://www. solvay-pharma.ru/files/articles/10046/1257496922390.pdf (дата обращения - 2.02.2010).
2. Душкин М.И. Макрофаги и атеросклероз: патофизиологические и терапевтические аспекты // Бюл. СО РАМН. 2006. № 2. С. 47-55.
3. Запорожец Т.С., Майстровский К.В., Раповка В.Г. и др. Роль Т-клеточной дисфункции в развитии атеросклероза сосудов нижних конечностей и возможности ее коррекции // Тихоокеанский мед. журн. 2009. № 3. С. 110-115.
4. Майстровский К.В., Запорожец Т.С., Федянина Л.Н. и др. Влияние иммуномодулятора фукоидана из бурых водорослей Fucus evanescens на показатели антиоксидантной системы, липидного и углеводного обмена у мышей // Тихоокеанский мед. журн. 2009. № 3. С. 97-100.
5. Панин Л.Е. Обмен липопротеинов и атеросклероз // Бюл. СО РАМН. 2006. № 2. С. 16-22.
6. Chawla A., Repa J.J., Evans R.M., Mangelsdorf D.J. Nuclear receptors and lipid physiology: opening the X-files // Science. 2001. Vol. 294. P. 1866-1870.
7. Choi J.H., Kim D.I., Park S.H. et al. Effects of sea tangle (Laminaria japonica) extract and fucoidan components on lipid metabolism of stressed // Korean Fish. Soc. // 2001. Vol. 33, P. 124-128.
8. Han L.-K., Kensaku G., Hiromichi O. Anti-obesity effects of fucoidan prepared from Cladosiphon Okamuranus tokida (Okinawamozuku) // Jap. J. Constitut. Med. 2004. Vol. 66. P. 55-60.
9. Hansson G., Robertson A.-K., Soderberg-Naucler C. Inflammation and atherosclerosis // Annu.Rev. Pathol. Dis. 2006. Vol. 1. P. 297-329.
10. Gallaher D.D., Gallaher C.M., Mahrt G.J. et al. A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans // J. Am. Coll. Nutr. 2002. Vol. 21. P. 428-433.
11. Jun-O Jin, Hae-Young Park, Qi Xu, Joo-In Park, T.Zvyagintseva et al. Ligand of scavenger receptor class A indirectly induces maturation of human blood dendritic cells via production of tumor necrosis factor // Blood. 2009. Vol. 113, No. 23. P. 5839-5847
12. Kim M.J, Chang U.J, Lee J.S. Inhibitory Effects of fucoidan in 3T3-L1 adipocyte differentiation// Marine Biotechnology. 2009. Vol. 11. P. 557-562.
13. Mamo J.C.L., Elsegood C.L., Gennat H.C., Yu K. Degradation of сhylomicron remnants by macrophages occurs via phagocytosis // Biochemistry. 1996. Vol. 35. P. 10210-10214.
14. Wang S.Z., Bi A.F. Clinic observation of fucoidan on patients with hyperlipidemia // Med. J. Qilu. 1994. Vol. 16. P. 173-174
15. Yokota T., Nagashima M., Ghazizadeh M. Kawanami O. Increased effect of fucoidan on lipoprotein lipase secretion in adipocytes // Life. 2009. Vol. 84. P. 523-529.
Review
For citations:
, , , , , Maistrovsky K.V., Zaporozhetz T.S., Rapovka V.G., Zvyagintseva T.N., Shevchenko N.M. CORRECTING LIPID EXCHANGE IN PATIENTS WITH OBLITERATING ATHEROSCLEROSIS OF LOWER LIMB VESSELS WITH FUCUS EVANESCENS-DERIVED SULPHATED POLYSACCHARIDE. Pacific Medical Journal. 2010;(4):47-50. (In Russ.)
Views:
302
Email this article 